Your browser doesn't support javascript.
loading
Suppressor of cytokine signaling (SOCS)5 ameliorates influenza infection via inhibition of EGFR signaling.
Kedzierski, Lukasz; Tate, Michelle D; Hsu, Alan C; Kolesnik, Tatiana B; Linossi, Edmond M; Dagley, Laura; Dong, Zhaoguang; Freeman, Sarah; Infusini, Giuseppe; Starkey, Malcolm R; Bird, Nicola L; Chatfield, Simon M; Babon, Jeffrey J; Huntington, Nicholas; Belz, Gabrielle; Webb, Andrew; Wark, Peter Ab; Nicola, Nicos A; Xu, Jianqing; Kedzierska, Katherine; Hansbro, Philip M; Nicholson, Sandra E.
Afiliación
  • Kedzierski L; The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.
  • Tate MD; Department of Medical Biology, University of Melbourne, Parkville, Australia.
  • Hsu AC; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Australia.
  • Kolesnik TB; Monash University, Clayton, Australia.
  • Linossi EM; Priority Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute and The University of Newcastle, Newcastle, Australia.
  • Dagley L; The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.
  • Dong Z; Department of Medical Biology, University of Melbourne, Parkville, Australia.
  • Freeman S; The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.
  • Infusini G; Department of Medical Biology, University of Melbourne, Parkville, Australia.
  • Starkey MR; The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.
  • Bird NL; Department of Medical Biology, University of Melbourne, Parkville, Australia.
  • Chatfield SM; Shanghai Public Health Clinical Center and Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
  • Babon JJ; The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.
  • Huntington N; Department of Medical Biology, University of Melbourne, Parkville, Australia.
  • Belz G; The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.
  • Webb A; Department of Medical Biology, University of Melbourne, Parkville, Australia.
  • Wark PA; Priority Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute and The University of Newcastle, Newcastle, Australia.
  • Nicola NA; Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Parkville, Australia.
  • Xu J; The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.
  • Kedzierska K; Department of Medical Biology, University of Melbourne, Parkville, Australia.
  • Hansbro PM; The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.
  • Nicholson SE; Department of Medical Biology, University of Melbourne, Parkville, Australia.
Elife ; 62017 02 14.
Article en En | MEDLINE | ID: mdl-28195529
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Virus de la Influenza A / Transducción de Señal / Citocinas / Proteínas Supresoras de la Señalización de Citocinas / Receptores ErbB Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Elife Año: 2017 Tipo del documento: Article País de afiliación: Australia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Virus de la Influenza A / Transducción de Señal / Citocinas / Proteínas Supresoras de la Señalización de Citocinas / Receptores ErbB Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Elife Año: 2017 Tipo del documento: Article País de afiliación: Australia